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ABSTRACT 
 
Implantable devices are continuously proving to be an effective and reliable method of 
treatment for human patients in clinical settings. One example class of these devices is 
closed-loop or conditional-triggering implantable devices, which monitor physiological 
signals and provide necessary intervention only when necessary. Pacemakers are one of 
the most widely used conditional stimulating devices that continuously monitor the heart 
activity and electrically stimulate the heart only when abnormal conditions are detected. 
This thesis presents a closed-loop bladder function control system for rats. The bladder 
activity is monitored using a novel sensor in a less invasive manner than the traditional 
pressure sensors. A neuromodulation technique called optogenetics is used as the method 
of intervention to help control the bladder function. The battery-less implantable device is 
wirelessly powered via inductive resonance coupling to reduce the size of the implantable 
device by eliminating batteries and charging circuits. A custom-built iOS application 
monitors the bladder activity for abnormal behavior and triggers neuromodulation by 
sending a signal to the implanted device. In vivo experiments with rats demonstrate the 
feasibility of closed-loop implantable devices to modulate bladder function and lay the 
foundations for such implantable devices in clinical settings.  
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CHAPTER 1: INTRODUCTION 
 
1.1 Implantable Devices 
Since the first demonstration of electrical stimulation in a clinical setting 
in 1952, implantable devices have increasingly become a popular method of 
treatment. Generally, a medical device is referred to as “implantable” if it is 
surgically introduced into a living body and remains inside after the procedure. 
Such invasive introduction of foreign objects into the body is a challenging task 
requiring careful consideration of various engineering disciplines and medical 
sciences. Moreover, the risks of surgical complications are always present, but the 
potential benefits of these devices justify their needs and continuous development 
[1]. A wide variety of implantable devices exist, ranging from passive devices, 
such as artificial knees and hips, to more sophisticated systems such as cochlear 
implants and cardioverter defibrillators. In most cases, these devices need to be 
implanted to continuously monitor and/or provide treatment for certain organs.  
 
One method to maximize the efficacy of implantable devices is to develop 
a closed-loop feedback system. The ultimate goal of a closed-loop device is to 
continuously monitor certain organs or tissues and trigger a method of 
intervention to improve the organ functionality. A common example is the 
pacemaker, which is an implantable device that monitors the heart and intervenes 
by using electrical stimulation when abnormal heart rhythm is detected. Electrical 
stimulation via electrodes is a conventional method to activate or inhibit neurons 
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for these devices. While a very extensive understanding of the neural signals and 
organ function is needed to model such feedback systems, these devices enable a 
very consistent and reliable control of organ functions outside a clinical setting. 
This work presents a feedback system to help control bladder function using a 
novel bladder measurement method and an unconventional neuromodulation 
technique. 
 
1.2 Bladder Disease 
 This closed-loop system for rats can provide not only insight into the 
physiology of bladder function, but also lay out a foundation for developing 
similar devices for human beings. The most common bladder condition among 
patients in the United States is called interstitial cystitis (also known as bladder 
pain syndrome) [2]. Patients with this disease go through a wide range of 
symptoms and severity, most commonly pain associated with bladder filling and 
increased urgency and frequency of urination. While the pathogenesis of the 
disease is not fully understood, there have been successful treatments to reduce 
pain and alleviate the symptoms, such as electrical stimulation of the sacral nerve 
[3]. Despite its effectiveness, there are drawbacks to sacral nerve stimulation. 
Like most electrical stimulation, it is hard to localize, potentially causing off-
target side effects. Most importantly, sacral nerve stimulation is performed in a 
pre-programmed, rather than a conditional, manner which decreases its 
effectiveness over time. Thus, a spatially localized and conditional stimulation of 
the bladder function can greatly improve the care of patients suffering from 
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bladder conditions, and the system presented here attempts to provide a potential 
alternative to the sacral nerve stimulation with a conditional and spatially 
localized stimulation of the bladder. 
 
1.3 Overview 
 This thesis is divided into five chapters that contribute to the development 
of this system. Chapter 2 discusses the motivations to develop the system, along 
with potential benefits this study may have in different scientific fields. Chapter 3 
explains the development of each component in the implantable device and the 
closed-loop system. The engineering design choices and tradeoffs are explained in 
detail in this chapter. Chapter 4 presents the results and discussion of biology 
experiments conducted with the closed-loop system. Chapter 5 provides a 
summary of the work presented and provides potential future directions of 
research. While all the aspects of the system are mentioned, this thesis focuses on 
system-level design with an emphasis on the electronics.  
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CHAPTER 2: MOTIVATION AND BENEFITS 
 
2.1 Bladder Band Strain Sensor 
 Traditional bladder activity measurements utilize pressure transducers to 
monitor internal bladder pressure. This method applies for both animals and 
humans alike, with a few other options available for smaller animals such as rats. 
The two most common methods of studying bladder function in awake, 
unanesthetized rats utilize either pressure measurement catheters or metabolic 
cages. Metabolic cages integrate an analytical balance beneath a cage to measure 
the rats’ urination activity. While non-invasive, this method only provides limited 
information regarding the void volume and frequency. The more invasive, 
pressure measurement cystometry is conducted by inserting a catheter into the 
bladder wall which is tunneled subcutaneously to the back of the neck. This 
method allows direct measurement of intravesicular pressure to offer a better 
understanding of bladder activity, but requires an incision in the bladder wall 
which can affect the normal bladder behavior. Additionally, the connection of the 
catheter to an external system requires a special caging environment for the 
measurement and limits the rats’ movement. Several sensors and wireless 
measurement methods have been proposed as alternatives for monitoring bladder 
function, but have been limited to large animal species and also lack in vivo 
experiments [4-7]. 
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 The novel bladder band strain sensor presented here attempts to overcome 
most of the drawbacks associated with the bladder pressure transducers. By 
employing a biocompatible and flexible strain sensor, a less invasive method is 
used to monitor the bladder activity. The stretchable strain sensor is horizontally 
wrapped around the rat’s bladder to provide a relative measurement of the 
bladder’s physical dimensions. Because the bladder activity can be interpreted 
from expansions and contractions of the bladder, monitoring the physical size can 
be a viable method to understand bladder activity. This eliminates the need for an 
incision in the bladder wall, making the proposed sensor less invasive. Moreover, 
when the sensor is connected to an implantable device, the bladder activity can be 
measured in an awake, unanesthetized rat without the need of a tethered catheter. 
Figure 2.1 shows pictures of the traditional intravesicular pressure measurement 
and the novel strain sensor measurement. Details of the strain sensor and its 
correlation with the pressure measurement are given in subsequent chapters. 
 
2.2 Closed-loop Organ Function Control 
 As previously mentioned, the main objective of the implantable device is 
to modulate bladder function depending on acquired physiological signals from 
the strain sensor. The implantable device transmits the strain sensor 
measurements to an iPad, which has a custom-built iOS application that 
recognizes when the bladder is overactive. To alleviate overactive bladder 
conditions, electrical stimulation of the sacral nerve has proven to be an effective 
method to decrease the urinating urgency and frequency with constant 
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stimulation. A more effective method is conditional stimulation, which stimulates 
only at intervals when the bladder is overactive. Conditional stimulation has been 
shown to be as effective while mitigating some of the side effects due to constant 
stimulation [3]. However, a catheter measurement can only be used in a hospital 
setting with current technology, making it impossible to build an implantable 
device with transducers. Thus, the proposed strain sensor is not only less invasive, 
but also opens opportunities for integration with implantable devices that enable 
monitoring in a non-hospital setting. The system presented here exploits this 
opportunity to include a neuromodulation technique called optogenetics, which 
will be described next.  
 
2.3 Optogenetics 
 The neuromodulation used in this system is a technique called 
optogenetics, which combines optics and genetics to control genetically modified 
neurons [8]. Traditional stimulation of nerves incorporates electrical stimulations, 
which have inevitable side effects. The most common side effect is the non-
specific targeting of neurons, which introduces the possibility of off-target nerve 
activation. Optogenetics, on the other hand, uses genetically encoded light-
sensitive channels to modulate neural activity. When neurons are genetically 
encoded, optics at a certain wavelength trigger neural activity by reacting to 
photosensitive proteins. This technique enables stimulation of the specific neural 
population that has been genetically encoded and completely avoids off-target 
stimulation [8].  
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For the experiments presented here, optogenetic inhibitory pumps called 
Archaerhodopsins are used to activate optogenetic proteins. The neuromodulation 
of the bladder function utilizes a 450 nm (green) light illumination to these 
encoded neurons, which causes silencing of neural activities. Until recently, most 
optogenetics experiments were carried out with optical fibers and lasers that were 
tethered inside the animals, severely limiting their natural behavior. While new 
studies have just started exploring the possibilities of building miniaturized 
implantable devices for optogenetic experiments [9], the device presented here 
incorporates µ-iLEDs with the strain sensor such that it can intimately interface 
with the genetically encoded region of the bladder. Triggering of the µ-iLEDs 
with a microcontroller enables high temporal precision that can be either pre-
programmed or set using an external device. The integrated µ-iLEDs for 
optogenetics are shown in the strain sensor in Figure 2.1, and a simplified closed-
loop system is illustrated in Figure 2.2.  
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2.4 Figures 
 
   
 
 
Figure 2.1: Comparison between rat bladder activity measurement using a 
pressure transducer (left) and strain sensor with integrated µ-iLEDs (right). The 
transducer is inserted into the bladder wall through an incision, while the strain 
sensor is wrapped around the bladder, eliminating the need to make an incision. 
 
 
 
 
Figure 2.2: Schematic illustration of conditional neuromodulation using µ-iLEDs. 
The iOS application determines whether bladder activity is abnormal. 
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CHAPTER 3: DEVELOPMENT 
 
3.1 Overview 
 The closed-loop system can be divided into four subsystems: strain 
sensor/µ-iLEDs, powering circuit, Bluetooth controller, and the iOS application 
software. Figure 3.1 is a block diagram of the system, with components color-
coded according to the four subsystems. First, the strain sensor/µ-iLEDs 
component is designed to safely interface with the bladder and includes the 
accompanying analog signal conditioning circuitry. Second, the powering circuit 
includes the components that are required to wirelessly deliver power to the 
implantable device and is composed of the primary coil driver, primary coil 
antenna, intermediate resonator, load coil antenna, supercapacitors and the power 
supply circuitry. Third, the Bluetooth microcontroller functions as the main 
controller of the implantable device with an embedded Bluetooth stack (S110, 
Nordic Semiconductor Inc.) that controls the wireless communication. The 
microcontroller is responsible for acquiring the sensor signals and triggering the 
µ-iLEDs. The last component is the iOS application which receives measurements 
from the implantable device and evaluates the bladder activity. When abnormal 
condition is detected through the software, it sends a signal to the implantable 
device to trigger the µ-iLEDs, thus closing the loop. Each component is explained 
in detail in the following sections. 
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3.2 Integrated Strain Sensor and µ-iLEDs 
     3.2.1 Strain Sensor 
 A strain sensor is a piezoresistive device used to measure strain on an 
object. Traditionally, metal strain sensors (or strain gauge) have been commonly 
used to measure the applied strain on an object. Due to the piezoresistive nature, 
when strain is applied on the object, the attached strain sensor deforms, thereby 
changing the resistance of the strain sensor. By monitoring the resistance of the 
strain sensor, the strain applied on the external object can be inferred from the 
properties of the strain sensor material. The gauge factor is an important property 
of a strain sensor, which characterizes the sensitivity of the device and can be 
expressed as 
 
 GF = 	 ∆&/&∆(/( = ∆&/&)  (3.1) 
 
where R is the original strain gauge resistance, L is the original length of the strain 
gauge, and 𝜀 is the applied strain on the strain gauge along the direction of L. 
Thus, the gauge factor is the ratio of relative resistance change to the applied 
mechanical strain, effectively characterizing the resistive sensitivity.  
 
 The strain sensor used to monitor bladder activity for this closed loop 
system is a biocompatible and stretchable strain sensor that is able to detect the 
relative change of the bladder’s physical dimensions. To integrate the strain 
sensor onto the bladder without constricting its natural movement, the strain 
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sensor needs to have a modulus close to, or lower than, that of the rat’s bladder. 
Therefore, the substrate of the strain sensor is fabricated on a material called Eco-
flex (Ecoflex 00-30, Smooth-On Inc.) which has a low modulus of 60 kPa. 
Carbon-doped (15%) Eco-flex is embedded inside the substrate in an 8 mm by 
300 µm rectangular geometry with a thickness of ~15 µm and acts as the actual 
piezoresistive sensor as seen in Figure 3.2a. The carbon-doped Eco-flex is 
patterned with ends coinciding to gold layer pads which are interconnected by 
serpentine traces to another set of pads where 8 cm 40-gauge wires are connected 
to the wireless base station of the implantable device as shown in Figure 3.2b.  
 
Mechanical measurements characterizing the strain sensor are plotted in 
Figure 3.2c-d, where the resulting elastic modulus is ~75 kPa and gauge factor is 
~2, representing that the change in relative resistance is ~2 times that of the 
change in strain. While the change in bladder dimension during contraction and 
expansion varies significantly among rats and with the exact positioning of the 
strain sensor, in vivo experiments have shown that the change in resistance is 
roughly 20% of the initial resistance. Moreover, the strain sensor’s initial 
resistance also varies due to imperfections in fabrication, ranging from 300 kΩ to 
500 kΩ. Because there is no gold standard in measuring the modulus of the rats’ 
bladder [10], cystometries were conducted on the same rats to verify that the 
bladder activity was not affected by the strain sensor applied on the bladder.  
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     3.2.2 Sensor Signal Conditioning 
 A Wheatstone bridge circuit is utilized to measure the resistance of the 
strain sensor, which corresponds to the relative size of the bladder. The bridge 
circuit indirectly measures an unknown resistance by comparing it with other 
known resistances, usually operating in a balanced bridge configuration. The 
bridge circuit with the strain sensor, including the remaining analog front-end 
circuit, is shown in Figure 3.3. As seen in the figure, the output of the bridge 
circuit, VB, is a differential voltage between two voltage-dividing resistor arms, 
where one of the four resistors is the strain sensor, RS. Because the strain sensor 
lengths were chosen to match the circumference of the empty bladder, the bridge 
resistances are chosen to match the initial resistance of the strain sensor, 
effectively nulling the differential voltage when the bladder is emptied. The 
differential voltage, VB, with the strain sensor at its initial state can be calculated 
as 
 
 𝑉, = 	𝑉-- 	 &.&./&0 − 23 	  (3.2) 
 
As previously mentioned, experiments have shown that the resistance of the strain 
sensor is initially ~300 kΩ to ~500 kΩ and ~1.2 times the initial resistance when 
the bladder fully expands. Then the differential voltage, VB, when strain is 
applied, assuming R1 is matched to RS, can be calculated as 
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 𝑉, = 	𝑉-- 	 &./∆&&./&0/∆& − 23 = 4556 	 ∆&&./∆78  (3.3) 
 
Due to the ∆𝑅 term in the denominator of the right hand side of (3.3), it is 
important to note that the output voltage is not strictly linear with respect to the 
strain sensor resistance and has a worst-case non-linearity error of 0.5 %/%. 
However, it will be shown that such error is negligible due to other sources of 
error and noise. Evaluating (3.3), the sensitivity and the accuracy of the bridge 
measurement system are calculated. The sensitivity of the system, which 
corresponds to the full-range output with 1 V excitation voltage is found in (3.4), 
assuming initial sensor resistance of  500 kΩ. 
 
 Sensitivity = 26	 2BB	CDEBB	CD/0FF	GH8 = 45	[mv/V] (3.4) 
 
To fully utilize the VDD swing with the strain sensor resistance, the output of the 
bridge circuit needs to be amplified such that the range of the strain sensor 
resistance corresponds to the supply voltage for maximum resolution. Since the 
bridge circuit has a high output impedance (~250 kΩ), a buffer at the input stage 
of the amplifier is needed for proper loading onto the amplifier. A convenient way 
to implement the buffer is by using an instrumental amplifier (INA333, Texas 
Instruments), which has a buffer at both terminals of the input stage. Advantages 
of using an instrumental amplifier with a bridge circuit include convenient gain 
modification, high common-mode rejection ratio (~110 dB), low system noise 
 14 
(~10	nV	 Hz), and direct radiometric output [11]. As seen in Figure 3.3, the 
buffered differential input voltage is applied along RT, forcing a current flow 
from Vo to the ground node. Therefore, this resistor effectively sets the gain of the 
system which is finally passed through an internal unity-gain differential 
amplifier. Then, the output of the overall amplifier stage can be expressed as  
 
  𝑉U = 1 + 3	×	EB,BBB&Y 	×	𝑉, =	 4556 1 + 3	×	EB,BBB&Y 		 ∆&&./∆78  (3.5) 
 
The gain is set to match the output of the amplifier swing to a resistance range 
corresponding to the initial sensor resistance to twice its initial resistance. In the 
example of a 500 kΩ strain sensor, the gain resistor, RG, is calculated as  
 
 𝑅Z = 2BBZ[\]^2 = 2BB__	×	.`abcdcecdf^2 	= 20	kΩ	 (3.6) 
 
for a gain of 6 and a range from 500 kΩ to 1MΩ. This leaves an upper margin in 
cases the strain sensor is relatively more sensitive or the initial resistance drifts 
upwards. The instrumental amplifier draws a quiescent current of 50 µA and the 
bridge circuit consumes 3 µA for a total power consumption of  159 µW in the 
analog sensor component.  Finally, the output of the instrumental amplifier is 
connected to an analog input of the microcontroller, which utilizes an internal 
analog-to-digital converter to digitally transmit the strain sensor reading to the 
iPad.  
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     3.2.3 µ-iLEDs 
 The µ-iLEDs used to neuromodulate the bladder are embedded in the 
substrate of the strain sensor to closely interface with the bladder. To ensure 
activation of the optogenetic proteins, optical density of 1 mW/mm2 is required at 
the location of target neurons [12]. As previously shown in Figure 2.1, the outer 
encapsulation of the strain sensor/µ-iLEDs is physically in contact with the 
bladder tissue, minimizing absorption and scattering of the optical power in the 
surrounding tissues. Two commercial µ-iLEDs (C527TR2227-0213, Cree Inc.) 
are soldered onto the gold pads that are patterned along with the strain sensor 
pads, and interconnected to the other set of gold pads where the 40-gauge wire is 
connected. The micro-scaled (220 µm ×  270 µm × 50 µm) and low-powered (2 
mW turn-on) devices allow miniaturized integration on the strain sensor with 
minimal power consumption. Although the power consumption is very low with a 
turn-on voltage of ~2 V , the µ-iLEDs still generate a certain level of heat at the 
surface, which can distort the bladder’s normal activity. To operate the µ-iLEDs 
at the organ temperature, the temperature at the substrate of the µ-iLEDs should 
not exceed ~38 °C. In order to find the current that corresponds to this 
temperature change, temporal temperature measurements are recorded using an IR 
camera and plotted in Figure 3.4. Measurements indicate that a 2.7 V and 3.3 mA 
applied on each µ-iLED corresponds to optical density of 50 mW/mm2 and is 
thermally safe. Therefore, a current-limiting resistor with a transistor (RUM001, 
Rohm Semiconductor) is used to set the current to 3.3 mA for each µ-iLED as 
shown in Figure 3.5. 
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3.3 Powering Scheme 
 The implantable device is a battery-less system powered wirelessly using 
resonant inductive coupling. This enables the device to operate without bulky 
batteries, allowing virtually infinite device lifetime and further miniaturization of 
the implantable device. However, resonant inductive coupling has severe 
drawbacks, such as sensitivity to angle mismatches, antenna dimension 
mismatches, and antenna separations, necessitating careful system-level design 
considerations [13]. The overall setup of wireless powering is given in Figure 3.6. 
As seen in the figure, the base station of the implantable device, which includes 
the load coil antenna, is subcutaneously implanted near the upper abdomen. Then, 
placing the primary coil antenna below the cage parallel to the cage floor allows 
the wireless powering antennas to be parallel to each other most of the time, while 
also minimizing the variability of the distance between the primary and load 
antennas. However, the angle between the two might vary if the rat were to stand 
up, which would significantly decrease the power transfer efficiency. As a 
countermeasure, supercapacitors are utilized to act as a short-term energy buffer 
in case of insufficient power delivered during periods of mismatched angles. 
Therefore, the overall powering scheme integrates wireless power transfer (source 
driver, primary coil antenna, intermediate resonator, load coil antenna), 
supercapacitors, and voltage regulating circuitry, which are described next.  
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     3.3.1 Wireless Power Transfer 
 Ampere’s law states that the magnetic field around an area is proportional 
to the amount of current flowing through the enclosed area, and Faraday’s law 
demonstrates that a varying magnetic flux through a loop conductor induces an 
electromotive force (EMF) on the conductor. Therefore, when a varying current is 
driven in a coil, it generates an induced EMF in any coils in the vicinity. These 
simple electromagnetic laws laid the foundation of non-radiative wireless power 
transfer using inductive coupling. In inductive coupling, mutual inductance 
characterizes how much voltage is induced relative to a current excitation on the 
other coil, and the coupling coefficient is the ratio of flux generated at one coil to 
the amount of flux flowing through the second coil, which can be expressed as  
 
  𝑘 = k(0(8 (3.7) 
 
where L is the self-inductance of each coil and M is the mutual inductance. The 
mutual inductance is governed by the geometry and the separation of the coils. 
Another important characteristic of a coil antenna is the Q factor, which describes 
how under-damped a coil is, and can be found as 
 
  𝑄 = mnom7` = p(	 2^p8(q^r78s& 	 (3.8) 
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where Z is the impedance and ω is the self-resonant frequency of the coil. The Q 
factor is an important parameter characterizing an antenna as it is directly related 
to the efficiency in inductive coupling. If these values are known, the Q factor and 
coupling coefficient can be used to calculate the exact wireless power transfer 
efficiency as  
 
  𝜂 = u8v0v82/ 2/u8v0v8 8 (3.9) 
 
While finding exact analytical solutions is difficult, estimates of these values 
provide reasonable design guidelines for wireless power transfer systems. For 
implantable devices, the sizes are severely limited, creating a low upper limit for 
the mutual coefficient and transfer efficiency with the primary coil antenna. 
Furthermore, the primary coil driver (usually a class-C or class-E amplifier) has a 
finite source resistance, which limits the Q factor of the primary coil antenna. To 
overcome these limitations, a high Q factor resonator is incorporated to increase 
the transfer efficiency with more positional freedom of the load coil antenna. By 
including an intermediate resonator, the transfer efficiency becomes the product 
of the efficiency between two stages of coils, which results in a higher overall 
transfer efficiency.  
 
The source antenna is driven with a commercial 13.56 MHz RFID driver 
(Feig Electronics Inc.), which includes an automated impedance matching circuit. 
The intermediate resonator consists of a wire surrounding the bottom of the cage, 
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which acts as the resonator coil, and a capacitor to match the self-resonant 
frequency at 13.56 MHz. Then, the automated impedance matching feature is 
used to set the source parameters to maximize the transfer efficiency with the 
resonator loaded. Normally, the loading of the resonator onto the antenna affects 
the impedance seen at the source and the resonator, making it difficult to match 
the impedance. However, the automated impedance matching feature enables 
precise impedance matching of the system to utilize a resonant inductive coupling 
setup. Finally, the load coil, which is on the substrate of the implantable device, is 
implanted inside the rat and placed inside the cage.  
 
While the load coil of the implantable device also includes an impedance 
matching circuit to match resonance at 13.56 MHz, the amount of current flowing 
to the load determines the load resistance and thus the Q factor. Nevertheless, the 
high Q factor of the resonator allows sufficient wireless power transfer. The 
power consumption of the implantable device is dominated by the µ-iLEDs, 
which require 19.8 mW when turned on (remaining circuit consumes <1 mW). 
Power transfer efficiency can be modeled using the lumped circuit model as 
shown in Figure 3.7, where the mutual inductance and self-inductance are found 
using a finite element method software (Ansys HFSS, Ansys Inc.). Measurements 
confirm that the implantable device in the cage receives a maximum of 38 mW at 
the edge of the cage and 21 mW at the center of the cage when the transmitting 
antenna is driven with 5 W.  
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     3.3.2 Supercapacitor and Magnetic Shielding 
 To overcome angle sensitivity limitations associated with magnetic 
resonance coupling, two 70 mF 3.3 V commercial supercapacitors (XH414H-
IV02E, Seiko Instruments) are incorporated in the circuit to act as an energy 
buffer. Supercapacitors are electrochemical double-layer capacitors that utilize 
high surface area carbon to deliver high energy densities compared to 
conventional capacitors. Unlike batteries, supercapacitors can be 
charged/discharged instantaneously, thus eliminating the current-regulating 
circuitry. Therefore, the received power in the load coil is converted to DC 
voltage using a full-bridge rectifier, which is then stepped down using a 3.2 V 
charge pump DC/DC voltage converter to limit overcharging of the 
supercapacitor. The output of the voltage converter is connected in parallel to the 
supercapacitor and then passed through a 3V low-dropout regulator for a steady 
supply voltage. Energy stored in the supercapacitor can be calculated using (3.10), 
to get a value of 0.72 J when charged to 3.2 V. 
 
  𝑊 =	 𝑉 𝑞 	d𝑞vB = 23 𝐶𝑉3  (3.10) 
 
Since the amount of wireless power received depends on the location inside the 
cage, the time to charge the supercapacitor varies, but takes ~10 seconds on 
average and ~30 seconds in the worst case scenario. When the supercapacitors are 
charged to 3.2 V, they supply energy for the implantable device to operate for at 
least 2 minutes when the µ-iLEDs are on, without any external power. Because 
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the rats generally do not stay standing up more than a couple seconds, such setup 
was enough to reliably power the implantable device for long-term experiments. 
Finally, the output of the LDO is connected to the rest of the implantable device 
system as the low-noise power supply voltage.  
 
 The supercapacitors are encapsulated with metal, which produces eddy 
currents when exposed to strong magnetic fields. Eddy currents are current loops 
induced in a conductor by a varying magnetic field. These currents are 
problematic because they counteract the original magnetic field, create ohmic 
losses, and generate significant heat inside the conductor. Therefore, the 
temperature-sensitive supercapacitors need magnetic shielding to prevent eddy 
currents from forming. To prevent magnetic fields from reaching the 
supercapacitor, the fields are redirected using ferromagnetic shielding material (µ’ 
= 150 at 13.56 MHz; 354001, Wurth Elektronik) underneath the supercapacitor. 
The ferrite material’s low magnetic reluctance redirects the incoming magnetic 
fields towards the planar direction of the ferrite sheet. Because the redirected 
fields decrease the amount of magnetic flux flowing through the load coil, 
ferromagnetic material is placed only in the region underneath the supercapacitor 
to minimize its effect on the inductive coupling. On the other hand, the 
ferromagnetic material can be used to shield the entire implantable device if a 
layered printed circuit board is utilized, where the system is layered in the order 
of load coil antenna, ferrite material, and the PCB. This would allow the 
maximum flux flow through the load coil while shielding the circuitry from 
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magnetic fields. A photograph of the implantable device is shown in Figure 3.8 
and the overall power circuit is shown in Figure 3.9. 
 
3.4 Bluetooth Microcontroller 
 Among various wireless communication protocols, Bluetooth is one of the 
most convenient and flexible methods to implement in resource-constrained 
devices, while consuming the least amount of power. Although communication at 
2.4 GHz is susceptible to absorption and scattering in biological tissue, 
subcutaneous implantation allows 2.4 GHz signals to be transmitted with minimal 
distortion. Measurements have shown that transmitting antenna power of -12 dBm 
from the implantable device was sufficient to reliably communicate with the iPad 
placed ~1 m away. An ultra-low power Bluetooth microcontroller (nRF51822, 
Nordic Semiconductor Inc.) is used as the main controller for the implantable 
device. The nRF51822 is a system on chip (SoC) that integrates 2.4 GHz radio 
transceiver, flash memory, ARM Cortex-M0 CPU, and various analog/digital 
peripherals. A precompiled Bluetooth Low Energy (BLE) protocol stack, S110 
SoftDevice (Nordic Semiconductor Inc.), is programmed into the microcontroller 
to enable flexible and convenient BLE integration with the programmable ARM 
Cortex-M0. Both the microcontroller and the communication protocol operate at 
extremely low duty cycles (~1%), allowing the device to be in sleep mode most of 
the time, thus minimizing average power consumption (< 1 mW). The embedded 
firmware is developed with Keil Tools software (ARM Ltd.) to sample the strain 
sensor signal and transmit it to the iPad, allowing power-consuming computations 
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and signal processing to be carried out on the iPad, while the implantable device 
only acquires and transmits the signal.  
 
     3.4.1 Firmware Development 
 The Bluetooth stack contains layers that govern the communication link. 
First, Generic Access Profile (GAP) is the lowest layer of the Bluetooth stack 
which controls connections and advertising of devices. In a Bluetooth connection, 
a central device is the device that initiates a connection (iPad) to the resource-
limited peripheral device (implantable device). The central device responds to 
advertising packets sent from a peripheral device with a scan response to initiate a 
connection. Therefore, an existing GAP profile was modified to create a unique 
profile for the developed closed-loop system. Next, General Attribute Profile 
(GATT) is the layer where actual data is transferred. The peripheral is the GATT 
server which holds the data to be transferred and the central is also known as the 
GATT client. The GATT layer includes services and characteristics which 
describe what kind of data will be transferred. These profiles are written in the 
firmware of the implantable device for the master device to recognize. For the 
closed-loop system, a new service profile was created to communicate using 
Bluetooth protocol. It includes two new characteristics that are communicated 
between the master and slave: strain sensor data and the LED status. The strain 
sensor reading characteristic contains the reading of the strain sensor and is 
updated by the implantable device every predefined connection interval (1 s), and 
the LED status characteristic is controlled by the central device which the 
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software controls depending on the strain sensor readings. Figure 3.10 shows a 
visual illustration of Bluetooth communication protocol.  
 
Since the interval between bladder contractions is in the sub-hour range, a 
1 s sampling interval is more than enough to capture the organ’s activity. 
Therefore, the microcontroller is programed to run a one second timer using an 
internal RC peripheral circuit upon initiating a Bluetooth connection. Then, 
whenever this timer resets, an analog-to-digital interrupt handler is called to read 
the analog voltage from the strain sensor. Because the noise of the strain sensor 
measurements is dominated by motion artifacts of the rat, an internal 8-bit 
converter is sufficient for the conversion. The 8-bit ADC’s least significant bit has 
a magnitude of  
 
  𝐿𝑆𝐵 = ~3 = 11.7	mV	 (3.11) 
 
which corresponds to a relatively large error margin of the ADC. This is the 
largest noise source of the system, but is considerably smaller than the noise 
generated from the motion artifacts. If the system requires a lower level of noise, 
an external ADC can be utilized for a higher resolution conversion and lower 
noise level. Following the ADC, the digital signal is stored in a TX buffer before 
being transmitted to the master device at the next connection interval. For the 
LED triggering, a general-purpose input/output pin of the microcontroller is used 
to switch the LED-driving transistor. Similarly, this pin can be updated at each 
 25 
connection interval if the iPad transmits an update characteristic signal. 
Connection between the implantable device and iPad continues until it is 
manually disconnected by the master device or the implantable device does not 
receive an update for over 6 seconds (maximum supervision timeout, 
predetermined by Bluetooth protocol [14]). 
 
3.5 iOS Application 
The final subsystem of the closed-loop system is the custom-built iOS 
application. The iOS software is designed to identify abnormal conditions and 
trigger the µ-iLEDs by sending a signal to the implantable device. Most of the 
software development came after data was collected and analyzed from in vivo 
experiments, which are discussed in detail in the next chapter.  
 
The iOS application was developed using Objective-C in Xcode by 
referring to a sample application provided by Nordic Semiconductor called “nRF 
Master Toolbox.” A Cocoa plotting framework for iOS, Core Plot, was used to 
plot the received measurements and analyzed data on the user interface, and 
CoreBluetooth was used to control the communication received from the 
implantable device. The user interface included different measurements and tools 
depending on the stage of the biology experiments. Initially, the software only 
displayed the strain sensor readings, but the software was eventually updated such 
that the received data was plotted on the user interface along with the analysis of 
the raw signal. Moreover, the raw signal was stored in a text data file in the iPad 
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for further offline analysis. While a detailed investigation of the strain sensor 
measurement is given in the next chapter, an example strain sensor measurement 
of the bladder is shown in Figure 3.11. In the given measurement, the sudden 
decrease in resistance corresponds to the urinating points where the bladder size 
decreases as it voids. These timestamps, and possibly the size of these peaks, are 
the necessary information to analyze bladder activity. Therefore, the iOS 
application is programmed to collect the data from the implantable device, and 
use a peak finding algorithm to find these urinating timestamps. Once the 
software detects a voiding event, it calculates the average interval between 
previous voids to determine whether voids are too frequent. If the average interval 
falls below a certain threshold, the iPad updates the LED status characteristic to 
trigger the µ-LEDs in the implantable device. Detailed void detecting steps are 
given in the next chapter. 
 
3.6 Device Integration 
Final steps before implanting the device include integration and 
encapsulation of the implantable device. The PCB of the implantable base station 
is fabricated on a flexible PCB material (Cu/PI Pyralux, DuPont), where the 
layout of the PCB is defined using photolithography and etching of the copper 
layer. Then, after soldering components onto the PCB layout, the wires 
connecting the strain sensor and the µ-iLEDs are soldered onto the defined pads 
of the wireless base station. The base station is then encapsulated using a thin 
layer of epoxy followed by dip-coating with butyl and PDMS. These layers 
 27 
provide a mechanically robust layer that is able to withstand biofluid penetration, 
while the outer PDMS layer keeps the implantable device biocompatible. The 
wireless base station has a long diameter of 3 cm, thickness of 1.8 mm, and 
weighs 420 mg. For in vivo experiments, the device is surgically implanted into 
the rat with the bladder sensor being secured using a buckle and an opening 
fabricated at each end of the strain sensor. The base station is then inserted 
between the skin and the muscle near the upper abdomen. Finally, the strain 
sensor measurements are recorded following ~2 days of recovery on the iPad. 
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3.7 Figures 
 
 
 
Figure 3.1: Schematic block diagram of the closed-loop system. Components are 
color-coded according to the four subsystems: strain sensor/µ-iLEDs (blue), 
powering circuit (orange), Bluetooth controller (purple), and the software (iPad). 
 
 
 
Figure 3.2: Characteristics of the strain sensor. (a) Illustration of the strain sensor 
including actual dimensions. (b) Illustration example of strain sensor wrapped 
around the bladder. (c) Stress-strain curve of the strain sensor. (d) Relative 
resistance change plotted against applied strain. 
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Figure 3.3: Circuit diagram of the strain sensor and analog front end. The internal 
circuitry of an instrumental amplifier is shown in the bigger red-dashed box, and 
the bridge circuit in the smaller red-dashed box. The input VDD is connected from 
the output of the power supply circuitry, and VO is connected to the input of the 
microcontroller.  
 
 
      
 
Figure 3.4: Characteristics of the µ-iLEDs. I-V curve and the corresponding 
measured optical power intensity (left) and theoretical/experimental temperature 
increment at the surface of the encapsulation at intensities of 50 mW/mm2 and 
100 mW/mm2 (right). 
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Figure 3.5: µ-iLED driver circuit. A current-limiting resistor is used to limit the 
current through each µ-iLED at 3.3 mA.  
 
 
 
 
 
 
Figure 3.6: Setup overview of wireless powering (top). Illustration of device 
implantation inside a rat (bottom). The device is implanted subcutaneously in the 
abdomen such that the load coil antenna is parallel to the primary coil antenna and 
the intermediate resonator when the rat is standing on four legs.  
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Figure 3.7: Lumped circuit model of wireless power transfer elements. Driver 
amplifier and the impedance matching circuit are omitted for simplicity. The 
inductors are a lumped representation of the loop antennas. 
 
 
 
 
  
 
 
Figure 3.8: Supercapacitor and magnetic shielding. Photograph of the implantable 
device (left). The load coil is the antenna used for resonant inductive coupling. 
Effect of ferrite shield (right). An example electromagnetic simulation of H-fields 
being shielded with a ferrite shield. [15] 
 
 
 
 
 
 
 
 
 
 32 
 
 
 
 
Figure 3.9: Summary of the overall powering scheme, including wireless power 
transfer components, impedance matching capacitor, voltage converters, and a 
low dropout regulator. The output of the low dropout regulator acts as the power 
supply voltage for the rest of the implantable device. 
 
 
 
 
 
 
 
 
 
Figure 3.10: Bluetooth communication protocol. Diagram of initiating a 
connection, data transfer communication, and GATT profile structure [16].  
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Figure 3.11: Example strain sensor measurement for 7 hours in an awake animal 
recorded with an iPad. 
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CHAPTER 4: RESULTS AND DISCUSSION 
 
 Following the development and testing phase of the implantable device, in 
vivo experiments were conducted at Washington University in St. Louis School of 
Medicine. The set of experiments were designed to determine the feasibility of 
using these strain sensors to monitor bladder activity for rats. Then, tests were 
conducted to see if the device was capable of activating optogenetic proteins for 
neuromodulation. Finally, based on the collected in vivo data, parameters for the 
closed-loop system were established. The conditional neuromodulation shown 
here is a preliminary result and research is ongoing to refine the closed-loop 
system with a higher level of accuracy and consistency. 
 
4.1 Strain Sensor and Optogenetics 
 After the strain sensor was developed and tested in vitro, pressure 
measurements and strain sensor measurements on anesthetized rats were 
compared side by side to observe the correlation. The goal of the experiments was 
to verify the feasibility of the strain sensor as an alternative to the pressure 
measurements and prove that the strain sensor did not constrict the bladder’s 
natural behavior. An example comparison of the two measurements is shown in 
Figure 4.1. As shown in the figure, the resistance measurement very closely 
resembles the pressure inside the bladder, confirming the strain sensor’s utility in 
monitoring the bladder activity. One unexpected challenge was that the exact 
location of the strain sensor significantly altered the amount of change in 
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resistance applied on the strain sensor. Another important observation with the 
measurements was that the strain sensors were able to detect non-voiding 
contractions of the bladder, which are not detectable using metabolic cages. This 
demonstrated that the strain sensor can measure the bladder activity as well as the 
pressure transducers, but in a less invasive method. Moreover, cystometry 
experiments on the same rats with and without the strain sensor verified that the 
strain sensor did not constrict the bladder’s natural movements. On the other 
hand, the slippery biofluids on the rats’ bladder made it difficult for the strain 
sensor to always stay in the same position for some experiments. Thus, further 
research is ongoing to develop a mechanism to keep the strain sensor fixed at a 
particular position. Otherwise, the strain sensor proved to be a promising method 
of measuring bladder activity.  
 
Then, optogenetics experiments were conducted to test if the developed 
device was able to activate the optogenetic proteins. The main goals of these 
closed-loop systems were to identify overactive bladder activity and help alleviate 
the conditions by delaying contraction intervals. Figure 4.2 shows an example 
measurement of an optogenetic experiment on anesthetized rats. A comparison 
between a control rat and a transgenic rat offers evidence of optogenetics as a 
method to delay contractions. The contraction interval increased ~20% for the 
transgenic rats when the LEDs were on, while no changes were observed on the 
control rat. 
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4.2 Void Identification 
 After the initial experiments verified the feasibility of these devices, many 
iterations of in vivo experiments were carried out to collect strain sensor 
measurements in awake animals. In parallel, the rats were placed in metabolic 
cages which have an integrated scale that monitors the voiding events. By 
comparing the strain sensor measurements to the metabolic cage data, a method to 
identify the voiding events was developed. Because the strain sensor is very 
sensitive to mechanical contact, results demonstrated that the motion artifacts 
were a very big source of noise. However, the voiding events were clearly 
distinguishable with sudden drops in the resistance despite the noise. An example 
measurement in an awake rat is shown in Figure 4.3a.   
 
To find an automated void identification method, various data analyses 
with large sets of strain sensor data were conducted. A simple method that 
resulted in an accurate algorithm included using a 120-point moving average 
filter, down-sampling, and calculating the derivative. First, the moving average 
filter removes most of the motion artifacts and higher frequency noise. Next, 
because the contractions following a voiding event take about 1 minute, the signal 
is down-sampled to 1 sample/min. Then, the derivative of the 1 sample/min data 
highlights the voiding event with a large negative slope. Then, when the 
derivative falls below the preset threshold of 10 units/s (determined from 
experiments), the software determines that a voiding cycle has occurred and 
records it.  
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4.3 Closed-loop System 
The final step in the biology experiments was to demonstrate the 
possibility of the closed-loop system. A virus was introduced to rats to cause 
cyclophosphamide (CYP)-induced cystitis, which is a temporary condition that 
increases the voiding frequency. It was observed that normal rats urinate about 
once every hour, and the rats with cystitis urinate two to three time times every 
hour during the daytime. Therefore, the first preliminary closed-loop parameters 
were established by defining a threshold contraction interval. Every time voiding 
events are recorded in the software, the software recalls three recent voiding 
timestamps to calculate the average contraction interval. When the voiding 
frequency exceeds 1.5/hour, the software sends a signal to turn on the LEDs to 
inhibit bladder function, and increase the contraction intervals. While the initial 
parameters were set and simulated using Matlab to test its functionality, the entire 
closed-loop in vivo experiments have not yet been conducted. However, most of 
the supporting experiments and simulations have been successful, and simulations 
with real measurements have shown conditional triggering at the correct times. 
Further research is ongoing to determine a refined algorithm to better differentiate 
between normal and abnormal bladder behavior, which will allow a more precise 
control of the bladder function using optogenetics. An example comparison 
controlled inhibition of the bladder is shown in Figure 4.4.  
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4.4 Figures 
 
 
 
Figure 4.1: Comparison of strain sensor measurement and pressure measurement 
of the bladder on an anesthetized rat. The strain sensor measurement is very 
closely correlated to the pressure measurement, confirming the feasibility of using 
the strain sensors to monitor bladder activity.  
 
 
 
 
Figure 4.2: Example measurements during an anesthetized optogenetic 
experiment for a control and transgenic rat. The green region corresponds to the 
time the LED is on. Note that the contraction interval increases when the LED is 
on. 
 
 39 
 
 
 
 
 
Figure 4.3: Step-by-step analysis of peak identification algorithm. (a) Raw data 
collected wirelessly from implanted strain sensor. (b) 150-point moving average 
filtered data. (c) Down-sampled to point per 60 samples. (d) Derivative of the 
down-sampled data. The detected voids by the software are marked in red stars in 
(a). 
 
 
 
Figure 4.4: Comparison of CYP rats’ bladder activity with and without 
optogenetics. The plots show strain sensor recordings during the day. The red box 
shows the strain sensor measurement of a rat where optogenetics was not 
triggered. In the blue box, optogenetics is triggered manually. With the LED on, it 
can be seen that the contraction intervals are not as short as the ones on the left. 
The yellow arrows correspond to voids detected by the software and the red arrow 
corresponds to confirmed voids from the metabolic cage. 
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CHAPTER 5: CONCLUSION 
 
 This thesis introduces an implantable device that is capable of 
conditionally inhibiting bladder activity to potentially help alleviate abnormal 
bladder conditions. The iOS software included in the system is to conveniently 
analyze data and control parameters during biology experiments. With more 
experimental data, it would be possible to embed the closed-loop algorithm into 
the implantable device firmware and remove the need for wireless communication 
with a user interface. Then, like a pacemaker, the device would be implanted for 
continuous monitoring and consistent treatments in a non-hospital environment. 
Moreover, the developed strain sensor shows potential to be used as an alternative 
bladder measurement method, which is much less invasive than the pressure 
measurement. Since this research is in its beginning stage, there are various areas 
that can be improved. 
 
5.1 Future Work 
Many choices in the design of this closed-loop system were made out of 
convenience in order to simplify and accelerate the design process. Therefore, 
there is room to significantly improve the performance of the device, while 
further miniaturizing it. Designing an application-specific integrated circuit 
(ASIC) would be a time-extensive process, but could significantly minimize the 
device dimension and power consumption. With more in vivo data, a refined 
algorithm can be designed and built into the ASIC such that an external software 
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and user interface is not necessary. Moreover, if the signal needs to be acquired 
wirelessly, the communication protocol and radio telemetry can be custom built to 
minimize power consumption at a frequency less susceptible to 
absorption/scattering in biological tissues. Such optimizations can decrease the 
power to a µW range, which can decrease the size of the wireless power receiving 
antenna. However, wireless powering will be more challenging with larger 
animals due to its angle sensitivity and larger antenna dimension mismatch. A 
possible solution would be to build the implantable device with batteries and a 
wireless charging circuit to charge the batteries during inactivity. Also, additional 
sensors can be utilized near the strain sensor to differentiate motion artifacts from 
the strain sensor signal. Finally, research is ongoing to improve the mechanics of 
the device encapsulation to make the device more compliant in a physiological 
setting. 
 
5.2 Future Research Directions 
The next step in research is to utilize the system to help further understand 
the bladder function and expand it for larger animals. While the strain sensor 
developed here is in a band geometry to fit experiments with rat bladders, similar 
strain sensors with different geometries can be developed to fit experiments for 
larger animals and potentially humans. Assuming a similar approach is possible, it 
will not only eliminate the need to use invasive pressure catheters or nerve 
interfacing electrodes for bladder measurements, but also provide a unique 
method to study the bladder function. Next, further optogenetics experiments will 
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help advance the neuromodulation methods to help alleviate bladder conditions. 
Although optogenetics is a relatively new technique, ongoing human trials prove 
that the technique is promising for clinical applications as well [17]. Finally, by 
utilizing the versatile Bluetooth platform (or ASIC), the system can be easily 
modified to incorporate different types of sensors (electrical recording or 
pressure) and actuators (electrical stimulation or microfluidic drug delivery) for a 
more sophisticated closed-loop system interfacing different organs.  
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